Salidroside is isolated from Rhodiola rosea and reduces HIF-1α and LOXL2 expression levels in the human pancreatic cancer cell line BxPC-3, inhibiting its proliferation and invasion under hypoxia. This evidence concerns the gene LOXL2 and pancreatic neoplasm.